MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02394cam a2200313 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
924120754X |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
924120754X |
| 035 ## - |
|---|
| -- |
(Sirsi) 924120754X |
| 060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QV 268.5 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
870804s1987 eng |
| 110 2# - MAIN ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
WHO Scientific Group on Progress in the Development and Use of Antiviral Drugs and Interferon. |
| 242 10 - TRANSLATION OF TITLE BY CATALOGING AGENCY |
|---|
| Title |
Les progrès de la mise au point et de l' utilisation des antiviraux et de l' interféron : |
| Remainder of title |
rapport d'un Groupe scientifique de l' OMS [réuni à Genàve du 10 au 13 mars 1987] |
| 242 10 - TRANSLATION OF TITLE BY CATALOGING AGENCY |
|---|
| Title |
Progresos en el desarrollo y uso de medicamentos antivirales e interferones : |
| Remainder of title |
informe de un Grupo Científico de la OMS [se reunió en Ginebra del 10 al13 de marzo de 1987] |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Progress in the development and use of antiviral drugs and interferon : |
| Remainder of title |
report of a WHO Scientific Group [meeting held in Geneva from 10 to 13 March 1987] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Geneva : |
| Name of publisher, distributor, etc. |
World Health Organization, |
| Date of publication, distribution, etc. |
1987. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
25 p. |
| 440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| Title |
World Health Organization technical report series ; |
| Volume/sequential designation |
no. 754 |
| 520 3# - SUMMARY, ETC. |
|---|
| Summary, etc. |
Meets the urgent need for a perspective on the current and future place of antiviral drugs and interferons in the treatment of viral diseases. Prepared by a 19-member group of experts, the report reviews and interprets recent findings that can either aid the safe and appropriate use of existing antivirals or guide the targeted search for new agents. Specific topics covered include the various approaches taken for the development and synthesis of antiviral agents, their mode of action and pharmacology, their safety and efficacy, the viral diseases for which antiviral agents are required, and the best strategies for treatment. By summarizing the main problems encountered during the development and testing of different agents, the report also offers a useful perspective on why certain lines of research failed and why certain drugs proved uncceptable. Throughout, an effort has been made to relate knowledge and experiences to the urgent search for an agent effective against HIV infections. |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
eng fre spa. |
| 550 ## - ISSUING BODY NOTE |
|---|
| Issuing body note |
WHODOC |
| 561 ## - OWNERSHIP AND CUSTODIAL HISTORY |
|---|
| History |
WHO monograph |
| 596 ## - |
|---|
| -- |
4 |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Antiviral agents. |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Interferons. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Communicable Diseases and their Control. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
World Health Organization. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://apps.who.int/iris/">https://apps.who.int/iris/</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
NLM Classification Scheme |
| Koha item type |
Books |
